-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Progyny, Raises Price Target to $33

Benzinga·09/08/2026 13:36:55
Listen to the news
Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $31 to $33.